Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
ESMO 2022
;
🎥Leonardo Provenzano, MD, from @IstTumori explores machine learning to predict early progression in HR+/HER2- advanced #breastcancer using data from the PALMARES-2 study:
➡️⬅️
@myESMO #ESMOBreast24
Predicting early progression in HR+/HER2- breast cancer with AI models
Leonardo Provenzano, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, examines the use of machine lea...
ow.ly
🎥@elisabettasabet of @IEOufficiale discusses the Phase III PREcoopERA trial on giredestrant in premenopausal ER+/HER2- #breastcancer:
➡️https://ow.ly/rOye50RJWy9⬅️
@myESMO #ESMOBreast24
🚨 Don't miss the latest episode of our weekly podcast!
This week we're showcasing highlights from #ESMOBreast24
👂Listen here:
#BreastCancer #BCsm @myESMO @OncoAlert
Key Updates at ESMO Breast 2024 - VJOncology
In today’s episode, we bring you key highlights from ESMO Breast 2024, diving into important discussions surrounding the latest research...
tinyurl.com
May is #SkinCancerAwarenessMonth 📣
According to The American Cancer Society an estimated 100,640 new #melanomas will be diagnosed in the USA in 2024 🇺🇸
Check out our skin cancer channel for the latest news and updates 👉 https://www.vjoncology.com/subject/skin-cancer
📢We’re so excited! Only two weeks to go until #ASCO24!
From May 31st we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️http://VJOncology.com⬅️
@ASCO @VJOncology
ESMO 2022
🎥Leonardo Provenzano, MD, from @IstTumori explores machine learning to predict early progression in HR+/HER2- advanced #breastcancer using data from the PALMARES-2 study:
➡️⬅️
@myESMO #ESMOBreast24
Predicting early progression in HR+/HER2- breast cancer with AI models
Leonardo Provenzano, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, examines the use of machine lea...
ow.ly
🎥@elisabettasabet of @IEOufficiale discusses the Phase III PREcoopERA trial on giredestrant in premenopausal ER+/HER2- #breastcancer:
➡️https://ow.ly/rOye50RJWy9⬅️
@myESMO #ESMOBreast24
🚨 Don't miss the latest episode of our weekly podcast!
This week we're showcasing highlights from #ESMOBreast24
👂Listen here:
#BreastCancer #BCsm @myESMO @OncoAlert
Key Updates at ESMO Breast 2024 - VJOncology
In today’s episode, we bring you key highlights from ESMO Breast 2024, diving into important discussions surrounding the latest research...
tinyurl.com
May is #SkinCancerAwarenessMonth 📣
According to The American Cancer Society an estimated 100,640 new #melanomas will be diagnosed in the USA in 2024 🇺🇸
Check out our skin cancer channel for the latest news and updates 👉 https://www.vjoncology.com/subject/skin-cancer
📢We’re so excited! Only two weeks to go until #ASCO24!
From May 31st we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️http://VJOncology.com⬅️
@ASCO @VJOncology
Latest videos from ESMO 2022!
View all
GU at ESMO 2022!
View all
GI at ESMO 2022!
View all
Breast cancer at ESMO 2022!
View all
Stay tuned for interviews with the following doctors and more...
